Riluzole vs placebo: Acceptability ‐ total dropouts
Riluzole showed no clear difference in acceptability ‐ total dropouts compared with placebo; GRADE not reported.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Riluzole vs placebo Acceptability ‐ total dropouts · depression in adults Riluzole showed no clear difference in acceptability ‐ total dropouts compared with placebo; GRADE not reported. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive… (2015) · Cochrane Headline outcomes onlyearlier version CD011612.PUB2, superseded | OR 0.81 [0.23, 2.88] | 1 study · 42 participants | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder 2021 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.